Beacon Biomedical

While our blood test cannot yet be utilized for ages under 45, this article alerts the younger crowd on the importance of keeping an eye on their colon health.
Although colon cancer is rare in this age group, it is rising and when found, it seems to be more aggressive. **alcancer

Colore**al Cancer: What Gen-Xers and Millennials Need to Know Colore**al cancer is on the rise among people younger than 50. Yale Medicine physicians say people as young as 20 need to know the signs and symptoms.

Curious to learn all about the latest medical technology innovations being developed here in Arizona? Join me at the ’s 2022 MedTech Conference on Tuesday, June 21 to hear from an accomplished line-up of healthcare innovators and the businesses and people who help build capacity for growth. Use promo code "15OFF" to get $15 off registration. Register now: https://bit.ly/3mbzcgN
Interact with engaging exhibits, ask questions of expert panels, and walk away with turnkey guidance and best practices for how to develop, test, and scale your own med-tech solution.
I’ll be part of the day long program. Our session is at 2-2:30PM. It’s a one-on-one discussion facilitated by the Arizona Commerce Authority with Beacon Biomedical (i.e. me as the CEO of Beacon) , and the session is entitled: Charting Your Path to Commercialization: How to Incorporate the SBIR Program into Your Company's Funding Model. #

2022 MedTech Conference Please join the Arizona Technology Council for its sixth annual MedTech Conference on Tuesday, June 21, 2022. A Field of Dreams: Capacity Counts! MedTech developed at a rapid pace over the past two years. There is no better time than now to stop and take a closer look at what will be needed